Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 31Stomach Neoplasms 4Neoplasms 4Cardiotoxicity 4Neoplasm Metastasis 3Brain Neoplasms 2Neurotoxicity Syndromes 1Neoplasms, Second Primary 1Neoplasm, Residual 1HER2-positive Breast Cancer 1HER2+ Breast Cancer 1Feasibility 1Fatigue 1Breast Cancer Organoids 1

Interventions

pyrrolidine 1pirarubicin 1olaparib 1ixabepilone 1exemestane 1eribulin 1apatinib 1Vinorelbine 1Trastuzumab 1Toremifene 1Tamoxifen 1Paclitaxel 1Methotrexate 1Letrozole 1Gemcitabine 1Fulvestrant 1Fluorouracil 1Epirubicin 1Endostatins 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1Carboplatin 1Capecitabine 1Bevacizumab 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Breast Cancer Organoids × Trastuzumab × Clear all
NCT03925233 2019-04-24

Breast Cancer Treatment Based on Organ-like Culture

Xijing Hospital

Unknown
300 enrolled
Breast

Breast Cancer Organoids

Data powered by HemOnc (CC BY 4.0) Colophon âš¡